Stay updated on Antiplatelet vs rtPA in Mild Stroke Clinical Trial
Sign up to get notified when there's something new on the Antiplatelet vs rtPA in Mild Stroke Clinical Trial page.

Latest updates to the Antiplatelet vs rtPA in Mild Stroke Clinical Trial page
- Check6 days agoChange DetectedThe page displays the NCT03661411 record for the ARAMIS trial comparing antiplatelet therapy with alteplase for acute mild ischemic stroke. It includes the study overview, eligibility criteria, interventions, outcome measures, status, and related publications.SummaryDifference52%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe footer revision label changed from v3.7.2 to v3.8.0; the page continues to display a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check27 days agoChange DetectedA site-wide NIH banner announces a terminology transition from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs. The study record remains a 403 error.SummaryDifference1%

- Check34 days agoChange DetectedThe footer revision label changed from v3.7.1 to v3.7.2 on the 403 error page.SummaryDifference0.2%

- Check41 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1; the page content remains a 403 error.SummaryDifference0.2%

- Check55 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study details, replacing the usual ClinicalTrials.gov content with an error screen and blocking access to the NCT03661411 study information.SummaryDifference19%

Stay in the know with updates to Antiplatelet vs rtPA in Mild Stroke Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Antiplatelet vs rtPA in Mild Stroke Clinical Trial page.